Ledger.Open graph →
SEC Form D · filed February 25, 2025

Grace Therapeutics, Inc

Offering
$30.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Princeton, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

S. George Kottayil · Princeton, NJDirectorA. Brian Davis · Trevose, PADirectorRobert J. Delaversano · Princeton, NJExecAmresh Kumar · Laval, Quebec, CanadaExecPrashant Kohli · Laval, Quebec, CanadaExec · DirectorCarrie D'Andrea · Laval, Quebec, CanadaExecEdward Neugeboren · Emeryville, CADirectorDr. R. Loch Macdonald · Laval, Quebec, CanadaExecVimal Kavuru · Laval, Quebec, CanadaDirectorRobert J. Delaversano · Princeton, NJExecAmresh Kumar · Laval, Quebec, CanadaExecPrashant Kohli · Laval, Quebec, CanadaExec · DirectorCarrie D'Andrea · Laval, Quebec, CanadaExecS. George Kottayil · Princeton, NJDirectorEdward Neugeboren · Princeton, NJDirectorA. Brian Davis · Trevose, PADirectorDr. R. Loch Macdonald · Laval, Quebec, CanadaExecVimal Kavuru · Laval, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗